Friday, January 31, 2025, 2:54PM |  42°
MENU
Advertisement
Pitt Bioforge — a collaboration between the University of Pittsburgh and a Massachusetts-based company that specializes in cell and gene therapy — is moving forward with the development of the planned $250 million biomanufacturing facility at Hazelwood Green  Credit: University of Pittsburgh
4
MORE

'Regionally transformative': Pitt pitches $250 million biomanufacturing facility at Hazelwood Green

University of Pittsburgh

'Regionally transformative': Pitt pitches $250 million biomanufacturing facility at Hazelwood Green

The facility will be 185,000 square feet with two pocket parks, bicycle parking, and integrated public art

The University of Pittsburgh is moving ahead with Pitt Bioforge, a planned $250 million biomanufacturing facility at Hazelwood Green.

The project, funded in part by a $100 million grant from the Richard King Mellon Foundation, is a collaboration between the university and a Massachusetts-based company that specializes in cell and gene therapy. The facility will produce cell and gene therapies for diseases that currently do not have any interventions, Pitt officials said, and could revitalize the region’s interest in the life sciences while being an economic driver to the community.

ElevateBio — a company focused on developing transformative cell and gene therapies — has partnered with Pitt under a 30-year agreement and will be an anchor tenant at the facility. Through the partnership, 170 full-time positions will be created, half of which will require trade-school or community college level certifications, according to the university.

Advertisement

Site prep for the facility is expected to begin late fall of this year with construction to begin in 2024, Pitt officials said. The facility will be 185,000 square feet with two pocket parks, bicycle parking, and integrated public art.

Hazelwood Green will be the site of a $250 million biomanufacturing facility being proposed by the University of Pittsburgh. Pitt is spending $10 million to acquire the land needed for BioForge, as the project is known.
Mark Belko
Pitt gets OK to spend $10 million to buy land for Hazelwood biomanufacturing complex

“The architecture of the new BioForge facility in the Hazelwood Green development strives to physically manifest the exciting, regionally transformative program it contains — biomanufacturing of cell and gene therapies,” Gina Bleck, Pitt’s vice chancellor for planning, design, and construction, said in a prepared statement.

“The exterior invites visual access to the science, and the entry element acts as a welcoming lantern to guide pedestrians into the building, a new icon for Pitt and the Pittsburgh region,” she continued. “The exterior amenities include ... opportunities for public art which will be collaborative with the Hazelwood neighborhood. While we continue to work on details, we are confident in the building design and think it will be an appealing addition to the Hazelwood neighborhood.”

The building will have LEED Gold certification, the second-highest credential one can obtain by addressing the carbon footprint of a building, the university said.

Advertisement

The University said it expects the facility to foster collaboration and serve as a long-term, place-based partnership with the community.

Ciara McEneany: cmceneany@post-gazette.com 

First Published: July 13, 2023, 3:53 p.m.

RELATED
David Hallal, ElevateBio chairman and CEO talks at a press conference announcing their plans to move into the University of Pittsburgh’s BioForge facility at Hazelwood Green.
Mark Belko
‘A transformative game-changer’: Firm specializing in cell and gene therapy to team with Pitt at Hazelwood Green
SHOW COMMENTS (0)  
Join the Conversation
Commenting policy | How to Report Abuse
If you would like your comment to be considered for a published letter to the editor, please send it to letters@post-gazette.com. Letters must be under 250 words and may be edited for length and clarity.
Partners
Advertisement
Downtown is being hit with another round of big property assessment cuts, delivering another blow to a city tax base already staggering.
1
business
'Death by a thousand cuts:' Downtown hit with another $64.9 million in assessment reductions
2
news
2 men found shot inside Bethel Park home, police say
Swissvale native Billy Gardell stars as "Pete," a house comic at the MGM Grand Casino, in "The Vortex."
3
a&e
Pittsburgh-native actor Billy Gardell gets starring dramatic role in 'The Vortex'
A house built in1862 is part of the former Morning Glory Inn at 2119 Sarah St. on the South Side
4
life
Buying Here: Former Morning Glory Inn on the South Side is priced at $1.25 million
Ohio State wide receiver Emeka Egbuka (2) catches a touchdown pass in front of Penn State linebacker Tony Rojas (13) during the first quarter of an NCAA college football game, Saturday, Nov. 2, 2024, in State College, Pa.
5
sports
Steelers mock draft tracker: Time to meet receivers Emeka Egbuka, Matthew Golden and Luther Burden III
Pitt Bioforge — a collaboration between the University of Pittsburgh and a Massachusetts-based company that specializes in cell and gene therapy — is moving forward with the development of the planned $250 million biomanufacturing facility at Hazelwood Green Credit: University of Pittsburgh  (University of Pittsburgh)
Pitt Bioforge — a collaboration between the University of Pittsburgh and a Massachusetts-based company that specializes in cell and gene therapy — is moving forward with the development of the planned $250 million biomanufacturing facility at Hazelwood Green Credit: University of Pittsburgh  (University of Pittsburgh)
Pitt Bioforge — a collaboration between the University of Pittsburgh and a Massachusetts-based company that specializes in cell and gene therapy — is moving forward with the development of the planned $250 million biomanufacturing facility at Hazelwood Green Credit: University of Pittsburgh  (University of Pittsburgh)
Pitt Bioforge — a collaboration between the University of Pittsburgh and a Massachusetts-based company that specializes in cell and gene therapy — is moving forward with the development of the planned $250 million biomanufacturing facility at Hazelwood Green Credit: University of Pittsburgh  (University of Pittsburgh)
University of Pittsburgh
Advertisement
LATEST business
Advertisement
TOP
Email a Story